(Q39475607)

English

Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis

scientific article published on May 1, 1995

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1 reference

based on heuristic

inferred from title

author name string

H. I. Katz

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585843

25 May 2024

J. S. Lindholm

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585843

25 May 2024

J. S. Weiss

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585843

25 May 2024

J. S. Shavin

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585843

25 May 2024

M. Morman

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585843

25 May 2024

R. Bressinck

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585843

25 May 2024

R. Cornell

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585843

25 May 2024

D. M. Pariser

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585843

25 May 2024

R. J. Pariser

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585843

25 May 2024

W. Weng

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585843

25 May 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7585843

25 May 2024

publication date

1 May 1995

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:0149291895801049?httpAccept=text/xml

1 reference

10.1016/0149-2918(95)80104-9

https://api.crossref.org/works/10.1016/0149-2918(95)80104-9

25 May 2024

https://api.elsevier.com/content/article/PII:0149291895801049?httpAccept=text/plain

1 reference

10.1016/0149-2918(95)80104-9

https://api.crossref.org/works/10.1016/0149-2918(95)80104-9

25 May 2024

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

390-401

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Natural history and treatment of scalp psoriasis

2

1 reference

10.1016/0149-2918(95)80104-9

https://api.crossref.org/works/10.1016/0149-2918(95)80104-9

25 May 2024

Guidelines for using superpotent topical steroids

4

1 reference

10.1016/0149-2918(95)80104-9

https://api.crossref.org/works/10.1016/0149-2918(95)80104-9

25 May 2024

A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis

6

1 reference

10.1016/0149-2918(95)80104-9

https://api.crossref.org/works/10.1016/0149-2918(95)80104-9

25 May 2024

Superpotent topical steroid treatment of psoriasis vulgaris--clinical efficacy and adrenal function

7

1 reference

10.1016/0149-2918(95)80104-9

https://api.crossref.org/works/10.1016/0149-2918(95)80104-9

25 May 2024

A double-blind, multicenter comparison between 0.05% halobetasol propionate ointment and 0.05% betamethasone dipropionate ointment in chronic plaque psoriasis

8

1 reference

10.1016/0149-2918(95)80104-9

https://api.crossref.org/works/10.1016/0149-2918(95)80104-9

25 May 2024

Diflorasone diacetate ointment 0.05% versus betamethasone dipropionate ointment 0.05% in moderate-severe plaque-type psoriasis

9

1 reference

10.1016/0149-2918(95)80104-9

https://api.crossref.org/works/10.1016/0149-2918(95)80104-9

25 May 2024

Hypothalamus-pituitary-adrenal axis suppression by superpotent topical steroids

10

1 reference

10.1016/0149-2918(95)80104-9

https://api.crossref.org/works/10.1016/0149-2918(95)80104-9

25 May 2024

Comparison of Hypothalamus-Pituitary-Adrenal Axis Suppression From Superpotent Topical Steroids by Standard Endocrine Function Testing and Gas Chromatographic Mass Spectrometry

11

1 reference

10.1016/0149-2918(95)80104-9

https://api.crossref.org/works/10.1016/0149-2918(95)80104-9

25 May 2024

Local treatment of psoriasis of the scalp with clobetasol propionate and betamethasone-17,21-dipropionate: a double-blind comparison

14

1 reference

10.1016/0149-2918(95)80104-9

https://api.crossref.org/works/10.1016/0149-2918(95)80104-9

25 May 2024

Betamethasone dipropionate cream for the treatment of psoriasis. A double-blind comparison with clobetasol propionate cream

16

1 reference

10.1016/0149-2918(95)80104-9

https://api.crossref.org/works/10.1016/0149-2918(95)80104-9

25 May 2024

Patient compliance and medical research: issues in methodology

18

1 reference

10.1016/0149-2918(95)80104-9

https://api.crossref.org/works/10.1016/0149-2918(95)80104-9

25 May 2024

Feelings of stigmatization in patients with psoriasis.

19

1 reference

10.1016/0149-2918(95)80104-9

https://api.crossref.org/works/10.1016/0149-2918(95)80104-9

25 May 2024

Identifiers

10.1016/0149-2918(95)80104-9

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39475607&oldid=2164228081"